Objective The traditional Chinese herbal formula, Jing-Ling Oral Solution (JLOS), has shown promising clinical efficacy in attention deficit hyperactivity disorder (ADHD). However, its pharmacological mechanisms remain unclear. This exploratory study aimed to investigate potential molecular mechanisms of JLOS in ADHD through an integrative approach combining network pharmacology and molecular docking. Methods Active ingredients and targets of JLOS were retrieved from the Traditional Chinese Medicine Systems Pharmacology Database (TCMSP) and the Bioinformatics Analysis Tool for Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM), while ADHD-related genes were sourced from GeneCards. A comprehensive "Herbs-Ingredients-Potential Targets" network was constructed using Cytoscape . Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed to identify biologically relevant processes and signaling pathways. Molecular docking simulations were conducted using AutoDock Vina via the CB-Dock server. Results We identified 76 active ingredients and 78 target genes of JLOS potentially involved in ADHD-related pathways. Network analysis revealed that quercetin and kaempferol were key bioactive components, interacting with 90 and 72 proteins, respectively. KEGG enrichment highlighted biologically relevant signaling pathways including neuroactive ligand-receptor interaction and inflammation-related pathways. GO analysis supported potential roles in regulating synaptic transmission, neurotransmitter activity and steroid response. AKT1 was identified as a core target based on highest degree centrality in the protein-protein interaction network. Conclusions These exploratory findings suggest that JLOS’s therapeutic effects in ADHD may arise from the synergistic orchestration of neurotransmitter pathways, synaptic plasticity, and inflammatory cascades. Network topology analysis identified quercetin and kaempferol as key bioactive constituents and AKT1 as a central hub target, all representing potential candidates for further experimental validation.